findmyKOL

David Sandler, MD

Basic profile

Oklahoma Heart Institute

ORCIDNone on fileNPI
RegionTulsa, OK · South CentralSpecialtyClinical Cardiac ElectrophysiologyFocusCardiology
Active KOLEmergingfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

David Sandler is a Cardiology physician affiliated with Oklahoma Heart Institute. OpenAlex indexes 31 publications with 507 citations (h-index 12).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
31publications

Distinct works indexed by OpenAlex.

507citations

Total citations across indexed works.

12h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
22companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1265 S Utica Ave
Suite 300
Tulsa, OK 741044243

Telephone

918-592-0999

Registry record last updated 18 Feb 2014.

View the NPPES registry record

Industry payments

22 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    54%
    Beta blocker23%
    Metoprolol Succinate49%Metoprolol Tartrate31%Carvedilol13%Sotalol5%Propranolol Hcl2%
    Part D<11 patients
    Antiarrhythmic17.3%
    Flecainide Acetate48%Amiodarone Hcl41%Multaq6%Dofetilide5%
    Part D<11 patients

    + 12 more classes in this area

  • Blood & clotting

    41.7%
    Factor Xa inhibitor37.7%
    Eliquis91%Xarelto9%
    Part D285 patients
    Vitamin K antagonist1.9%
    Warfarin Sodium100%
    Part D16 patients

    + 2 more classes in this area

  • Respiratory

    3.1%
    RNA Synthetase Inhibitor Antibacterial3.1%
    Mupirocin100%
    Part D97 patients
Where care is delivered (Part B)7.9% facility · 92.1% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”